Dogwood Therapeutics, Inc.
DWTX
$6.21
-$0.01-0.16%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -567.33% | -428.72% | -333.55% | -133.18% | 8.22% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4,095.33% | 1,654.95% | 1,632.23% | 556.39% | -14.60% |
| Change in Net Operating Assets | -319.41% | -1,597.74% | -385.68% | -198.87% | 333.46% |
| Cash from Operations | -338.74% | -276.91% | -205.05% | -80.48% | 32.02% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 201.05% | 67.60% | 403.70% | 25.60% | 25.60% |
| Repurchase of Common Stock | -71.65% | -- | -- | -- | 18.37% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1,533.24% | 762.63% | 1,982.06% | 1,344.53% | 29.13% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 394.47% | 761.35% | 613.36% | 410.47% | 45.10% |